Role of NK1 Receptor Antagonists in Treating CINV

Advanced Practice Providers

View More Breast Cancer Gastrointestinal Cancer Genetics Genitourinary Cancer Gynecologic Cancer Hematology Immuno-Oncology Lung Cancer Nurse Navigation Prevention Supportive Care

Breast Cancer Gastrointestinal Cancer Genetics Genitourinary Cancer Gynecologic Cancer Hematology Immuno-Oncology Lung Cancer Nurse Navigation Prevention Supportive Care

Medical World News

Medical World News Podcasts Videos

Conference Coverage

Conference Listing

Publications CME/CE

Subscribe Partners

CancerNetwork.com
CureToday.com
OncLive.com
TargetedOnc.com
Privacy
Terms & Conditions
Do Not Sell My Information

© 2022 MJH Life Sciences and Oncology Nursing News. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Specialty

Advanced Practice Providers

ClinicalSee All >

Breast Cancer
Gastrointestinal Cancer
Genetics
Genitourinary Cancer
Gynecologic Cancer
Hematology
Immuno-Oncology
Lung Cancer
Nurse Navigation
Prevention
Supportive Care

CancerNetwork.com
CureToday.com
OncLive.com
TargetedOnc.com
Privacy
Terms & Conditions
Do Not Sell My Information

© 2022 MJH Life Sciences^™ and Oncology Nursing News. All rights reserved.

July 24, 2017

Previous Video Next Video

Related Content:

VideosAdverse Event ManagementImmuno-Oncology

Approaches to Urothelial Care Call for Nuanced AE Management

Approaches to Urothelial Care Call for Nuanced AE Management

Evolution of Frontline VEGF TKI/Immunotherapy Treatments Propels Field of Renal Cell Carcinoma

Evolution of Frontline VEGF TKI/Immunotherapy Treatments Propels Field of Renal Cell Carcinoma

Paula Anastasia on PARP Inhibitor Ineligibility Factors for Women With Ovarian Cancer

Paula Anastasia on PARP Inhibitor Ineligibility Factors for Women With Ovarian Cancer